|
|
9 Oak Park Drive
Bedford, MA 01730 USA
phone:781-457-5000
fax:781-457-5011
|
|
| Symbol |
PODD |
| Exchange |
NASDAQ |
| Founded |
0 |
| Employees |
|
|
|
| www.myomnipod.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Treatment options for diabetes management through technology development. |
|
| Management |
| Duane DeSisto, President and Chief Executive Officer; Carsten Boess, Chief Financial Officer; Luis J. Malave, Chief Operating Officer; R. Anthony Diehl, Esq., General Counsel and Secretary; Ruthann DePietro, Vice President of Quality and Regulatory Affairs; John T. Garibotto, Vice President of Research, Development and Engineering; Shawna Gvazdauskas, Vice President of Sales; Kevin Schmid, Vice President of Manufacturing; Jeff Smith, Vice President of Marketing and Business Development |
| |
|
|
|
|
|
|
|
| Keywords |
| devices, technologies, Diabetes, blood sugar, diabetic, metabolic, insulin, treatment, medical, insulin |
|
|
|
| Description |
|
Insulet Corporation is a privately-held, innovative diabetes management company dedicated to providing superior treatment options and lifelong health benefits for people with diabetes. |
|
| Products / Services |
Insulet Corporation's first commercial product, the OmniPod Insulin Management System, has been specifically designed to break down the barriers to CSII therapy, improve health outcomes, and make diabetes a smaller part of life for diabetes patients.
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members